GSK Tells 3rd Circ. Avandia MDL Cases Can't Be Appealed
GlaxoSmithKline LLC on Wednesday said the Third Circuit has no authority to hear appeals in 10 personal injury lawsuits in multidistrict litigation over diabetes drug Avandia that were thrown out because...To view the full article, register now.
Already a subscriber? Click here to view full article